MTM1 and centronuclear myopathy: Finally, heterozygous pathogenic MTM1 variants were detected in two symptomatic female carriers with CNM, and one RYR1 missense variant previously considered as polymorphism has now been reclassified as a pathogenic variant in a CNM family [31].